Vertex Pharmaceuticals Just Made a Major Move: Is the Stock a Buy?
Vertex Pharmaceuticals just made aBold move that could reshape its growth trajectory. This guide breaks down the deal...
Knowing when to tweak your budget involves watching for spending spikes, debt creep, and goal drift. Make small, timely updates.
16,694 articlesVertex Pharmaceuticals just made aBold move that could reshape its growth trajectory. This guide breaks down the deal...
In a volatile market, the dividend growth approach that emphasizes rising payouts over big yields is drawing attentio...
Investors are buzzing about The Metals Company as a potential new source of critical minerals. This article weighs th...
A Wall Street titan is backing Crypto.com with a substantial investment, signaling a new era of cross-market liquidit...
AI-driven demand is reshaping chip markets, but selecting the right names matters. This guide highlights five semicon...
The 13F filings show billionaire david tepper goes big on Alphabet, Micron, and Meta, while dialing back on Alibaba a...
Kadant is navigating 2025 with a mix of packaging strength and manufacturing headwinds. This guide breaks down what t...
Moderna surged on pandemic-era demand. But what comes next? This piece examines why some investors are wary, what a t...
Investors looking at cannabis real estate need to understand how Innovative Industrial Properties reports earnings. T...
As AI expands data center demand, Micron sits at the center of memory supply. This guide breaks down the odds for 202...
A thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
A multi-jurisdictional probe led to indictments for 62 people connected to a massive crypto-laundering operation. The...